IPO
-
-
-
-
-
-
-
Aileron Therapeutics Reports Third Quarter 2018 Financial Results
-
-
-
-
-
-
-
Aileron Therapeutics (ALRN) Names Jeffrey A. Bailey to Board
-
-
-
-
-
-
-
Aileron Therapeutics Announces Pricing of Initial Public Offering
122,322 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

